SCHEMBL4259161

SCHEMBL4259161

CC1=C(C(=O)OC(c2ccccc2)C2CC2)C(c2cccc3ccccc23)n2nnnc2N1

nearest known ligand 0.52

Predicted protein targets (top 12)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 9/20 0.52
LMNA P02545 3/20 0.51
MAPT P10636 2/20 0.49
PKM P14618 1/20 0.48
SMN1; SMN2 Q16637 3/20 0.47
KMT2A Q03164 3/20 0.47
NPSR1 Q6W5P4 2/20 0.47
TP53 P04637 2/20 0.46
THRB P10828 1/20 0.46
HTT P42858 2/20 0.44
HPGD P15428 3/20 0.44
GAA P10253 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3004378 0.87 ALDH1A1 (0.56) ALDH1A1LMNAMAPTPKMSMN1; SMN2
SCHEMBL2994039 0.87 ALDH1A1 (0.56) ALDH1A1LMNAMAPTPKMSMN1; SMN2
SCHEMBL2994037 0.87 ALDH1A1 (0.56) ALDH1A1LMNAMAPTPKMSMN1; SMN2
SCHEMBL3223845 0.87 ALDH1A1 (0.56) ALDH1A1LMNAMAPTPKMSMN1; SMN2
SCHEMBL2999529 0.87 ALDH1A1 (0.56) ALDH1A1LMNAMAPTPKMSMN1; SMN2
SCHEMBL3006578 0.85 ALDH1A1 (0.56) ALDH1A1LMNAMAPTPKMSMN1; SMN2
SCHEMBL3005531 0.82 ALDH1A1 (0.55) ALDH1A1LMNAMAPTPKMSMN1; SMN2
SCHEMBL3248337 0.82 ALDH1A1 (0.75) ALDH1A1LMNAMAPTPKMSMN1; SMN2
SCHEMBL3250065 0.81 ALDH1A1 (0.53) ALDH1A1LMNAMAPTPKMSMN1; SMN2
SCHEMBL3115427 0.81 ALDH1A1 (0.57) ALDH1A1LMNAMAPTPKMSMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8716319-B2 Substituted heterocyclic compounds GILEAD SCIENCES, INC. (US) 2014-05-06 US disclosed
WO-2009006580-A1 OPTIONALLY CONDENSED DIHYDROPYRIDINE, DIHYDROPYRIMIDINE AND DIHYDROPYRANE DERIVATIVES ACTING AS LATE SODIUM CHANNEL BLOCKERS CV THERAPEUTICS, INC. (US) 2009-01-08 WO disclosed